These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15202722)

  • 21. The role of chemokines in rheumatoid arthritis and osteoarthritis.
    Vergunst CE; van de Sande MG; Lebre MC; Tak PP
    Scand J Rheumatol; 2005; 34(6):415-25. PubMed ID: 16393761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. XToll, a recombinant chaperonin 10 as an anti-inflammatory immunomodulator.
    van Eden W
    Curr Opin Investig Drugs; 2008 May; 9(5):523-33. PubMed ID: 18465663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The expression and function of chemokines involved in CNS inflammation.
    Ubogu EE; Cossoy MB; Ransohoff RM
    Trends Pharmacol Sci; 2006 Jan; 27(1):48-55. PubMed ID: 16310865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic potential of chemokine receptor antagonists for liver disease.
    Sahin H; Berres ML; Wasmuth HE
    Expert Rev Clin Pharmacol; 2011 Jul; 4(4):503-13. PubMed ID: 22114859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cloning, expression, and functional characterization of cynomolgus monkey (Macaca fascicularis) CC chemokine receptor 1.
    Gupta S; Schulz-Maronde S; Kutzleb C; Richter R; Forssmann WG; Kapp A; Forssmann U; Elsner J
    J Leukoc Biol; 2005 Nov; 78(5):1175-84. PubMed ID: 16204626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CP-481,715, a potent and selective CCR1 antagonist with potential therapeutic implications for inflammatory diseases.
    Gladue RP; Tylaska LA; Brissette WH; Lira PD; Kath JC; Poss CS; Brown MF; Paradis TJ; Conklyn MJ; Ogborne KT; McGlynn MA; Lillie BM; DiRico AP; Mairs EN; McElroy EB; Martin WH; Stock IA; Shepard RM; Showell HJ; Neote K
    J Biol Chem; 2003 Oct; 278(42):40473-80. PubMed ID: 12909630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of chemokine expression by interferon beta therapy in patients with multiple sclerosis.
    Cepok S; Schreiber H; Hoffmann S; Zhou D; Neuhaus O; von Geldern G; Hochgesand S; Nessler S; Rothhammer V; Lang M; Hartung HP; Hemmer B
    Arch Neurol; 2009 Oct; 66(10):1216-23. PubMed ID: 19667211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promiscuous drugs as therapeutics for chemokine receptors.
    Horuk R
    Expert Rev Mol Med; 2009 Jan; 11():e1. PubMed ID: 19123963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of chemokine activity by posttranslational modification.
    Mortier A; Van Damme J; Proost P
    Pharmacol Ther; 2008 Nov; 120(2):197-217. PubMed ID: 18793669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overcoming hurdles in developing successful drugs targeting chemokine receptors.
    Schall TJ; Proudfoot AE
    Nat Rev Immunol; 2011 May; 11(5):355-63. PubMed ID: 21494268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potent small molecule CCR1 antagonists.
    Kath JC; Brissette WH; Brown MF; Conklyn M; DiRico AP; Dorff P; Gladue RP; Lillie BM; Lira PD; Mairs EN; Martin WH; McElroy EB; McGlynn MA; Paradis TJ; Poss CS; Stock IA; Tylaska LA; Zheng D
    Bioorg Med Chem Lett; 2004 May; 14(9):2169-73. PubMed ID: 15081002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of C-C chemokine receptors 1 and 5 and CCL3/macrophage inflammatory protein-1alpha in the cutaneous Arthus reaction: possible attenuation of their inhibitory effects by compensatory chemokine production.
    Yanaba K; Mukaida N; Matsushima K; Murphy PM; Takehara K; Sato S
    Eur J Immunol; 2004 Dec; 34(12):3553-61. PubMed ID: 15517609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemokine receptor antagonists: Part 1.
    Pease JE; Horuk R
    Expert Opin Ther Pat; 2009 Jan; 19(1):39-58. PubMed ID: 19441897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel CCR1 antagonists with oral activity in the mouse collagen induced arthritis.
    Revesz L; Bollbuck B; Buhl T; Eder J; Esser R; Feifel R; Heng R; Hiestand P; Jachez-Demange B; Loetscher P; Sparrer H; Schlapbach A; Waelchli R
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5160-4. PubMed ID: 16198561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic targeting of chemokine signaling in Multiple Sclerosis.
    Hamann I; Zipp F; Infante-Duarte C
    J Neurol Sci; 2008 Nov; 274(1-2):31-8. PubMed ID: 18706659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Blockade of chemokines in chronic inflammatory diseases].
    Haringman JJ; Tak PP
    Ned Tijdschr Geneeskd; 2004 Sep; 148(36):1760-4. PubMed ID: 15495938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemokines and chemokine receptors as therapeutic targets in lupus nephritis.
    Vielhauer V; Anders HJ; Schlöndorff D
    Semin Nephrol; 2007 Jan; 27(1):81-97. PubMed ID: 17336691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoantigen signalling through chemokine receptors.
    Howard OZ
    Curr Opin Rheumatol; 2006 Nov; 18(6):642-6. PubMed ID: 17053513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delayed chemokine receptor 1 blockade prolongs survival in collagen 4A3-deficient mice with Alport disease.
    Ninichuk V; Gross O; Reichel C; Khandoga A; Pawar RD; Ciubar R; Segerer S; Belemezova E; Radomska E; Luckow B; Perez de Lema G; Murphy PM; Gao JL; Henger A; Kretzler M; Horuk R; Weber M; Krombach F; Schlöndorff D; Anders HJ
    J Am Soc Nephrol; 2005 Apr; 16(4):977-85. PubMed ID: 15716328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus.
    Henneken M; Dörner T; Burmester GR; Berek C
    Arthritis Res Ther; 2005; 7(5):R1001-13. PubMed ID: 16207316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.